Latest Asx Listing Rules News

Page 1 of 140
Flagship Minerals has withdrawn several historical sampling and drilling results from its Fortuna Valle announcement after identifying missing information required under ASX rules. The revised disclosure keeps the 265km² Chilean copper-gold option alive, but leaves investors with a large exploration package and a less complete evidence base.
Maxwell Dee
Maxwell Dee
19 Nov 2026
Golden Mile Resources has secured commitments for a $950,000 private placement to fund a 10-hole maiden drilling campaign at its Aurora Gold Prospect in Arizona. The raising comes with 95 million attaching options and shareholder approval still required for part of the issue.
Maxwell Dee
Maxwell Dee
19 Nov 2026
West Cobar Metals has been suspended from quotation after confirming it lacks enough directors to meet Corporations Act requirements. The suspension will remain until ASX is satisfied that the company has restored compliance and is suitable for reinstatement.
Maxwell Dee
Maxwell Dee
19 Nov 2026
Sunrise Energy Metals has received unconditional FIRB approval for its proposed move to the United States, removing a key condition for the scheme. The company is targeting shareholder and Court approvals in January, with Nasdaq and ASX CDI trading expected to begin in February 2027.
Maxwell Dee
Maxwell Dee
19 Nov 2026
Estrella Resources has withdrawn the production target and all forecast financial information from its Werumata Limestone Project scoping study after discussions with ASX. The company says the affected Years 11 to 20 mine plan relied predominantly on Inferred Mineral Resources and plans to issue a revised study based on a 10-year mine life.
Maxwell Dee
Maxwell Dee
18 Nov 2026
Lendlease has told the ASX it knows of no undisclosed information behind a sharp fall in its securities from $2.23 to $1.74. The company attributed the move to negative media coverage and reports from two brokers after its bond redemption announcement.
Victor Sage
Victor Sage
18 Nov 2026
EPX is seeking up to A$1.7 million through a placement and partially underwritten entitlement offer, with the funds aimed at installing new revenue-generating opportunities and supporting working capital. Up to A$500,000 may instead be needed for a disputed UAE employment matter.
Sophie Babbage
Sophie Babbage
18 Nov 2026
Genmin has secured another A$1.0 million in unsecured loans from entities associated with two directors, taking total director-associated borrowings to A$4.0 million. The funding provides interim working capital, but strategic partner negotiations for Baniaka remain non-binding and uncertain.
Maxwell Dee
Maxwell Dee
18 Nov 2026
Microba Life Sciences has been suspended from trading after revised terms for its proposed Genetic Signatures merger left it unable to complete the second tranche of its institutional placement. The company says it is assessing alternative funding while its cashflow runway narrows.
Victor Sage
Victor Sage
17 Nov 2026
Neometals has executed documentation for a proposed A$2 million secured convertible note, offering near-term working capital while adding a second lender to its Barrambie security structure. The notes carry 10% interest and could convert into shares at A$0.025, but have not yet been issued.
Victor Sage
Victor Sage
16 Nov 2026
BCAL Diagnostics, an 18.46% shareholder of Genetic Signatures, has asked the Takeovers Panel to intervene over the proposed merger with Microba Life Sciences. The application alleges the deal structure and shareholder process lack adequate protections, although no Panel has yet been appointed and no decision has been made.
Ada Torres
Ada Torres
13 Nov 2026
Genetic Signatures’ proposed Microba merger faces a formal challenge from 18.46% shareholder BCAL Diagnostics, which alleges the process lacks adequate protections and information for GSS investors. The Takeovers Panel has not yet appointed a sitting Panel or decided whether to open proceedings.
Ada Torres
Ada Torres
13 Nov 2026

Browse the archive

Full archive